Bale · Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2019 · prospective observational cohort study · n=50

Oxygen dependency of mitochondrial metabolism indicates outcome of newborn brain injury.

Cited 60 times in the scientific literature.

Level 3 - non-randomized controlled study

Prospective observational cohort study evaluating a prognostic physiological biomarker against a surrogate imaging outcome.

PubMed 29775114 · doi:10.1177/0271678X18777928 · record verified 2026-08-27

What was done

Broadband near-infrared spectroscopy (NIRS) was used to monitor cerebral oxygenation and mitochondrial metabolism (oxidation state of cytochrome-c-oxidase, CCO) in 50 neonates with hypoxic-ischaemic encephalopathy (HIE) receiving therapeutic hypothermia. Across 24 neonates, 54 spontaneous peripheral oxygen desaturation events were captured between 6 and 81 hours after birth. Cerebral metabolic responses to these desaturations were analyzed to evaluate their ability to predict injury severity, which was determined by magnetic resonance spectroscopy (MRS)-derived lactate/N-acetyl-aspartate ratios.

What was found

A strong coupling between NIRS-measured CCO and cerebral oxygenation during desaturation events was associated with an unfavorable outcome. A drop in brain tissue CCO oxidation state greater than 0.06 µM per 1 µM drop in brain hemoglobin oxygenation predicted unfavorable injury outcomes with 64% sensitivity, 79% specificity, and an area under the receiver operating characteristic curve (AUC) of 0.73.

Why it matters

Real-time bedside monitoring of mitochondrial CCO changes via broadband NIRS could provide an early, non-invasive indicator of cellular metabolic failure and injury severity during therapeutic hypothermia for neonatal HIE.

Limits

Although 50 neonates were monitored, analysis of oxygen dependency was limited to 24 neonates who experienced spontaneous desaturation episodes (54 total events). The outcome definition relied on MRS lactate/N-acetyl-aspartate ratios rather than long-term clinical neurodevelopmental outcomes. The predictive accuracy was modest (sensitivity 64%, specificity 79%, AUC 0.73), and the method requires further clinical and technical validation.

Cited by